Regulation of intestinal microbiota by the NLR protein family

International Immunology

Volumn 25, Issue 4, 2013, Pages 207-214

  Biswas, Amlan ^a,b,c   Kobayashi, Koichi S ^a,b,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Crohn's disease; Inflammasome; Microbiome; NLRP6; NOD2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 33; NUCLEOTIDE BINDING DOMAIN AND LEUCINE RICH REPEAT CONTAINING PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; CELL DIFFERENTIATION; CROHN DISEASE; ENTERITIS; ESCHERICHIA COLI; FEEDBACK SYSTEM; GENE MUTATION; HELICOBACTER HEPATICUS; HUMAN; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; MICROBIAL COMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; REVIEW; SYMBIOSIS;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; INTESTINES; METAGENOME; NOD2 SIGNALING ADAPTOR PROTEIN; SIGNAL TRANSDUCTION;

EID: 84875246938     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs116     Document Type: Review

References (73)

1. Hooper, L. V. and Gordon, J. I. 2001. Commensal host-bacterial relationships in the gut. Science 292:1115.
2. Guarner, F. and Malagelada, J. R. 2003. Gut flora in health and disease. Lancet 361:512.
3. Xavier, R. J. and Podolsky, D. K. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427.
4. Sartor, R. B. 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577.
5. Abraham, C. and Cho, J. H. 2009. Inflammatory bowel disease. N. Engl. J. Med. 361:2066.
6. Begue, B., Dumant, C., Bambou, J. C. et al. 2006. Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. J. Cell. Physiol. 209:241.
7. Hooper, L. V. and Macpherson, A. J. 2010. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10:159.
8. Nicholson, J. K., Holmes, E., Kinross, J. et al. 2012. Host-gut microbiota metabolic interactions. Science 336:1262.
9. The Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486:215.
10. The Human Microbiome Project Consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486:207.
11. Hooper, L. V., Littman, D. R. and Macpherson, A. J. 2012. Interactions between the microbiota and the immune system. Science 336:1268.
12. Macpherson, A. J. and Uhr, T. 2004. Compartmentalization of the mucosal immune responses to commensal intestinal bacteria. Ann. N. Y. Acad. Sci. 1029:36.
13. Johansson, M. E., Larsson, J. M. and Hansson, G. C. 2011. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1):4659.
14. Johansson, M. E. and Hansson, G. C. 2011. Microbiology. Keeping bacteria at a distance. Science 334:182.
15. Gallo, R. L. and Hooper, L. V. 2012. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12:503.
16. Salzman, N. H., Hung, K., Haribhai, D. et al. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:76.
17. Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y. and Bevins, C. L. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522.
18. Chu, H., Pazgier, M., Jung, G. et al. 2012. Human a-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337:477.
19. Ting, J. P., Lovering, R. C., Alnemri, E. S. et al. 2008. The NLR gene family: a standard nomenclature. Immunity 28:285.
20. Wilmanski, J. M., Petnicki-Ocwieja, T. and Kobayashi, K. S. 2008. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. J. Leukoc. Biol. 83:13.
21. Elinav, E., Strowig, T., Henao-Mejia, J. and Flavell, R. A. 2011. Regulation of the antimicrobial response by NLR proteins. Immunity 34:665.
22. Martinon, F., Burns, K. and Tschopp, J. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10:417.
23. Lamkanfi, M. and Dixit, V. M. 2009. Inflammasomes: guardians of cytosolic sanctity. Immunol. Rev. 227:95.
24. Boyden, E. D. and Dietrich, W. F. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38:240.
25. Cassel, S. L., Joly, S. and Sutterwala, F. S. 2009. The NLRP3 inflammasome: a sensor of immune danger signals. Semin. Immunol. 21:194.
26. Miao, E. A., Alpuche-Aranda, C. M., Dors, M. et al. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat. Immunol. 7:569.
27. Franchi, L., Amer, A., Body-Malapel, M. et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat. Immunol. 7:576.
28. Miao, E. A., Mao, D. P., Yudkovsky, N. et al. 2010. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc. Natl. Acad. Sci. U.S.A. 107:3076.
29. Miao, E. A., Leaf, I. A., Treuting, P. M. et al. 2010. Caspase-1- induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11:1136.
30. Bertin, J., Nir, W. J., Fischer, C. M. et al. 1999. Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB. J. Biol. Chem. 274:12955.
31. Inohara, N., Koseki, T., del Peso, L. et al. 1999. Nod1, an Apaf- 1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274:14560.
32. Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S. and Nunez, G. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276:4812.
33. Tada, H., Aiba, S., Shibata, K., Ohteki, T. and Takada, H. 2005. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect. Immun. 73:7967.
34. Hisamatsu, T., Suzuki, M., Reinecker, H. C., Nadeau, W. J., McCormick, B. A. and Podolsky, D. K. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993.
35. Uehara, A., Fujimoto, Y., Fukase, K. and Takada, H. 2007. Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol. Immunol. 44:3100.
36. Uehara, A., Sugawara, Y., Kurata, S. et al. 2005. Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell. Microbiol. 7:675.
37. Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schröder, J. M. and Harder, J. 2006. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J. Biol. Chem. 281:2005.
38. Gutierrez, O., Pipaon, C., Inohara, N. et al. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277:41701.
39. Caetano, B. C., Biswas, A., Lima, D. S., Jr et al. 2011. Intrinsic expression of Nod2 in CD4+ T lymphocytes is not necessary for the development of cell-mediated immunity and host resistance to Toxoplasma gondii. Eur. J. Immunol. 41:3627.
40. Girardin, S. E., Boneca, I. G., Viala, J. et al. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:8869.
41. Inohara, N., Ogura, Y., Fontalba, A. et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:5509.
42. Inohara, N., Koseki, T., Lin, J. et al. 2000. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:27823.
43. Abbott, D. W., Wilkins, A., Asara, J. M. and Cantley, L. C. 2004. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr. Biol. 14:2217.
44. Kobayashi, K. S., Chamaillard, M., Ogura, Y. et al. 2005. Nod2- dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307:731.
45. Petnicki-Ocwieja, T., Hrncir, T., Liu, Y. J. et al. 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U.S.A. 106:15813.
46. Rehman, A., Sina, C., Gavrilova, O. et al. 2011. Nod2 is essential for temporal development of intestinal microbial communities. Gut 60:1354.
47. Mondot, S., Barreau, F., Al Nabhani, Z. et al. 2012. Altered gut microbiota composition in immune-impaired Nod2(-/-) mice. Gut 61:634.
48. Ogura, Y., Lala, S., Xin, W. et al. 2003. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52:1591.
49. Lala, S., Ogura, Y., Osborne, C. et al. 2003. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125:47.
50. Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347:417.
51. Hugot, J. P., Chamaillard, M., Zouali, H. et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599.
52. Ogura, Y., Bonen, D. K., Inohara, N. et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603.
53. Lesage, S., Zouali, H., Cézard, J. P. et al. 2002. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70:845.
54. Cho, J. H. 2008. The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8:458.
55. Biswas, A., Petnicki-Ocwieja, T. and Kobayashi, K. S. 2012. Nod2: a key regulator linking microbiota to intestinal mucosal immunity. J. Mol. Med. 90:15.
56. Wehkamp, J., Salzman, N. H., Porter, E. et al. 2005. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U.S.A. 102:18129.
57. Simms, L. A., Doecke, J. D., Walsh, M. D., Huang, N., Fowler, E. V. and Radford-Smith, G. L. 2008. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57:903.
58. Perminow, G., Beisner, J., Koslowski, M. et al. 2010. Defective Paneth cell-mediated host defense in pediatric ileal Crohn's disease. Am. J. Gastroenterol. 105:452.
59. Biswas, A., Liu, Y. J., Hao, L. et al. 2010. Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc. Natl. Acad. Sci. U.S.A. 107:14739.
60. Cadwell, K., Liu, J. Y., Brown, S. L. et al. 2008. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259.
61. Kaser, A., Lee, A. H., Franke, A. et al. 2008. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134:743.
62. Cooney, R., Baker, J., Brain, O. et al. 2010. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat. Med. 16:90.
63. Homer, C. R., Richmond, A. L., Rebert, N. A., Achkar, J. P. and McDonald, C. 2010. ATG16L1 and NOD2 interact in an autophagydependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology 139:1630.
64. Travassos, L. H., Carneiro, L. A., Ramjeet, M. et al. 2010. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11:55.
65. Plantinga, T. S., Crisan, T. O., Oosting, M. et al. 2011. Crohn's disease- associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 60:1229.
66. Koslowski, M. J., Kübler, I., Chamaillard, M. et al. 2009. Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease. PLoS ONE 4:e4496.
67. Chen, G. Y., Liu, M., Wang, F., Bertin, J. and Núñez, G. 2011. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J. Immunol. 186:7187.
68. Elinav, E., Strowig, T., Kau, A. L. et al. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745.
69. Normand, S., Delanoye-Crespin, A., Bressenot, A. et al. 2011. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. U.S.A. 108:9601.
70. Kempster, S. L., Belteki, G., Forhead, A. J. et al. 2011. Developmental control of the Nlrp6 inflammasome and a substrate, IL-18, in mammalian intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G253.
71. Henao-Mejia, J., Elinav, E., Jin, C. et al. 2012. Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity. Nature 482:179.
72. Bouskra, D., Brézillon, C., Bérard, M. et al. 2008. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456:507.
73. Chen, G. Y. and Núñez, G. 2009. Gut immunity: a NOD to the commensals. Curr. Biol. 19:R171.